Table of Contents Table of Contents
Previous Page  73 / 604 Next Page
Information
Show Menu
Previous Page 73 / 604 Next Page
Page Background

Intern Med J.

2015 Sep;45(9):898-904. doi: 10.1111/imj.12857.

Management of refractory breathlessness with morphine in

patients with chronic obstructive pulmonary disease.

Smallwood N

1

,

Le B

2

,

Currow D

3

,

Irving L

1

,

Philip J

4

.

1

Department of Respiratory and Sleep Medicine, ²Palliative Care, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

3

Palliative and Supportive Services, Division of Medicine, Flinders University, Adelaide, South Australia, Australia.

4

Centre for Palliative Care, St Vincent's Hospital, Melbourne, Victoria, Australia.

-

Breathlessness

is common in advanced COPD and

remains undertreated

.

-As all reversible causes of breatlessness are being optimally managed,

low dose

morphine can reduce safely & effectively breathlessness

in patients with

severe COPD and refractory dyspnoea.

-Despite numerous guidelines recommending opioids in this clinical setting,

many barriers limit their uptake by clinicians

.

-

Integration of palliative care earlier in the disease course

can help to

improve symptom control for people with severe COPD and refractory

breathlessness.

Cancer